PTC Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Amgen USD 2.6B 507M 2025-03
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Cytokinetics 463K 79.14M 2024-09
Daiichi Sankyo JPY 92.35B 1.99B 2025-06
Gilead Sciences USD 1.54B 41M 2025-03
Incyte USD 78.77M 10.96M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Novartis USD 3.32B 95M 2025-06
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
TG Therapeutics USD 15.4M 6.06M 2024-12
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Xencor 10.71M 4.56M 2024-09


PTC Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.